Response by Fordyce et al to Letter Regarding Article, “On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.